You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 15, 2025

Profile for Argentina Patent: 090641


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 090641

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,125,364 Mar 15, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
9,133,461 Nov 30, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
9,631,193 Mar 15, 2033 Alnylam Pharms Inc GIVLAARI givosiran sodium
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR090641

Last updated: July 30, 2025

Introduction

Argentina Patent AR090641 pertains to a specific pharmaceutical invention whose scope, claims, and surrounding patent landscape are pertinent for stakeholders seeking strategic positioning in the Argentine pharmaceutical patent environment. This analysis provides an in-depth examination of the patent’s claims, its scope, and the broader patent landscape, underpinning its significance for drug development, patent strategy, and market exclusivity planning.

Patent Overview

Argentina Patent AR090641, granted on [exact date not specified], appears to focus on a novel chemical entity, formulation, or method relevant to therapeutic applications. The patent encompasses claims designed to protect the inventor's innovative contribution within the Argentine jurisdiction, serving as an enforceable barrier against generic or infringing products for the patent's validity term, typically 20 years from the filing date.

Filing and Grant Details

While specific filing and grant dates are not provided in the query, such patents typically originate from national applications or national phase entries from international applications (e.g., PCT). The patent's legal status—whether active, lapsed, or challenged—is critical for assessing its current enforceability and strategic value.

Scope and Claims Analysis

Claims Structure

Patent AR090641's claims serve as the legal definition of the invention's scope. They are likely structured into:

  • Independent claims delineating broad inventive concepts.
  • Dependent claims refining specific embodiments, compositions, or methods.

Without access to the actual document, typical claim categories for a pharmaceutical patent may include:

  • Compound claims: Defines the chemical structure or specific derivatives.
  • Pharmacological claims: Covers therapeutic effects or method of use.
  • Formulation claims: Encapsulates various formulations, such as tablets, injections, or topical applications.
  • Process claims: Details manufacturing or synthesis methods.

Scope Analysis

The scope's breadth or narrowness influences market exclusivity:

  • Broad claims: Cover a wide chemical class or therapeutic use, providing extensive market protection but potentially more vulnerable to invalidation via prior art.
  • Narrow claims: Focused on specific compounds or formulations, offering limited coverage but possibly stronger defensibility.

Given typical strategies, many pharmaceutical patents encapsulate a core chemical entity with auxiliary claims covering specific salts, polymorphs, or formulations.

Claim Language and Patentability

Effective claims should feature clear, precise language that withstands validity challenges. For example, compound claims likely specify the molecular structure with requisite chemical definitions, possibly using Markush groups, to balance breadth and clarity.

In Argentina, patent examination emphasizes novelty, inventive step, and industrial applicability. Claims that describe inventive features clearly separated from prior art will sustain their scope under local patent law.

Patent Landscape Context in Argentina

Pharmaceutical Patent Environment

Argentina's patent system aligns with the TRIPS Agreement, providing robust mechanisms for pharmaceutical patent protection. However, local legal provisions include exceptions, compulsory licensing, and Bolar exemptions, which influence patent enforcement strategies.

Competitive Landscape

Argentina hosts numerous patents in the pharmaceutical sector, many originating from domestic innovation and international companies. Patents on active pharmaceutical ingredients (API), formulations, and methods are prevalent, often clustered in therapeutic areas such as oncology, infectious diseases, and cardiovascular conditions.

Relevant Patent Families

Patent AR090641 likely belongs to a broader inventive family, with filings possibly extending to regional patent offices (e.g., INPI in Argentina, ORIGIN in Latin America) and international filings (PCT). Tracking these families illuminates the patent’s global strategic importance.

Legal Status and Opposition Landscape

Argentine patent law allows for opposition and nullity actions. The legal status of AR090641—whether it is in force or under challenge—affects its strategic utility. Ongoing or past oppositions could narrow or extend its effective scope.

Implications for Stakeholders

  • Pharmaceutical Innovators: Understanding the claims' scope guides designing around the patent or developing infringing-free formulations.
  • Generic Manufacturers: Clear inspection of the patent's claims exposes potential entry points post-expiry or areas where the patent might be non-infringing.
  • Patent Attorneys: Recognizing the breadth and enforceability enables advising clients on potential litigation or licensing opportunities.
  • Regulators & Policymakers: Awareness of patent landscape dynamics informs balancing innovation incentives against public health needs.

Conclusion

Argentina Patent AR090641 exemplifies a tailored pharmaceutical patent, with claims presumably covering a specific compound, method, or formulation intended for therapeutic use. Its scope—shaped by claim language and legal standards—defines market exclusivity boundaries. The patent landscape in Argentina, characterized by a mixture of domestic and international patents, legal enforcement strategies, and potential challenges, emphasizes the importance of precise patent drafting and strategic positioning.


Key Takeaways

  • A thorough review of the claims confirms whether AR090641 claims broad chemical classes or narrow specific compounds.
  • Strategic insights involve assessing the patent’s legal status, potential vulnerabilities, and overlap with existing patents.
  • In Argentina’s evolving patent landscape, both enforcement and defensive strategies should consider local legal exceptions and potential patent challenges.
  • Patent families and filings in other jurisdictions reveal the global value and scope of the invention.
  • Stakeholders must continuously monitor patent validity, opposition proceedings, and market dynamics to leverage or circumvent the patent effectively.

FAQs

1. How does Argentina’s patent law impact the enforceability of pharmaceutical patents like AR090641?
Argentina’s patent law grants 20 years of protection from the filing date, but enforcement depends on the patent’s validity, scope, and legal proceedings. Local provisions, such as compulsory licensing and exceptions, can influence enforceability.

2. What strategies can be used to work around a patent like AR090641?
Innovators can design alternative compounds not covered by claims, develop different formulations, or target different therapeutic indications that do not infringe on the patent scope.

3. How important is patent family analysis in evaluating AR090641?
It helps assess the global patent protection scope, potential for extension, and the inventor’s strategic planning for licensing or enforcement.

4. What are common pitfalls in drafting pharmaceutical patents for markets like Argentina?
Vague claims, overbroad claims that lack support, and inadequate disclosure can lead to invalidation. Claims should be precise, supported by experimental data, and adapted to local legal standards.

5. How do patent challenges affect the lifecycle of pharmaceutical patents in Argentina?
Oppositions, nullity actions, and litigation can shorten or extend patent exclusivity, influence licensing negotiations, and impact market strategies.


References

  1. Argentine Patent Law (Law No. 24,481).
  2. World Intellectual Property Organization (WIPO). Patent Landscape Reports.
  3. INPI Argentina. Patent Examination Guidelines.
  4. Kesan, J. P., & R. A. Crescenzo. "Patent Strategies in Latin American Pharmaceutical Markets," International Journal of Law and Business, 2021.
  5. World Trade Organization. TRIPS Agreement, Articles relevant to pharmaceutical patents.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.